Stay updated on Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now indicates no participants are being sought and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting and changes the release note from Revision: v3.5.5 to Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:39:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated to v3.5.5, indicating a software version update for the page. This change does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T16:26:00.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page has updated its revision number from v3.5.3 to v3.5.4, indicating a minor site update. The update does not alter the displayed study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T05:22:27.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.2 to v3.5.3, representing a new build of the site. This update does not alter the study details or any information presented to users.
    Difference
    0.1%
    Check dated 2026-04-30T18:35:02.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now shown, replacing Revision: v3.5.0. This indicates a site update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:12.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:44:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab as AML Post-Remission Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab as AML Post-Remission Treatment Clinical Trial page.